SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021414
Filing Date
2020-11-16
Accepted
2020-11-16 06:42:09
Documents
73
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1455147
2 ex10-57.htm EX-10.57 114155
3 ex10-58.htm EX-10.58 92393
4 ex10-59.htm EX-10.59 292126
5 ex31-1.htm EX-31.1 20657
6 ex31-2.htm EX-31.2 20780
7 ex32-1.htm EX-32.1 5781
8 ex32-2.htm EX-32.2 6011
  Complete submission text file 0001493152-20-021414.txt   6956098

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE matn-20200930.xml EX-101.INS 1011460
10 XBRL SCHEMA FILE matn-20200930.xsd EX-101.SCH 76565
11 XBRL CALCULATION FILE matn-20200930_cal.xml EX-101.CAL 54861
12 XBRL DEFINITION FILE matn-20200930_def.xml EX-101.DEF 367970
13 XBRL LABEL FILE matn-20200930_lab.xml EX-101.LAB 468773
14 XBRL PRESENTATION FILE matn-20200930_pre.xml EX-101.PRE 415982
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 201313586
SIC: 2834 Pharmaceutical Preparations